Venous Access Device Manufacturing in the US - Industry Market Research Report

Drawing blood: The industry will benefit from recent changes in Medicare and Medicaid reimbursements

Venous Access Device Manufacturers produce medical devices to access a patient's bloodstream to deliver various treatments, including hydration, nutritional infusion, antibiotics, chemotherapy and dialysis. The pandemic resulted in heightened demand for healthcare solutions, including medical procedures and other treatments, both boosting demand for venous access devices. According to Healthcare Global, a resource for healthcare-related industries, an estimated 90.0% of hospitalized patients in the United States receive vascular access treatment using venous access devices. An aging population has contributed to this trend, as having more people over the age of 50 results in higher spending on healthcare, supporting manufacturing performance. These factors are estimated to cause the industry to grow at an estimated CAGR of 1.9% to $6.9 billion over the past five years, including a 1.9% jump in 2023 alone.

Manufactures of venous access devices, such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports and catheter securement devices. Medical professionals use these devices to access a patient’s bloodstream through the veins and deliver a variety of treatments including hydration, nutritional infusion, antibiotics, chemotherapy and dialysis.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.